1 mg semaglutide to tirzepatide & are transforming diabetes & obesity management. These GLP-1 receptor agonists offer benefits from glycemic control weight loss and cardiovascular risk reduction, emphasizing their broad impact. Read more from The GLP-1 Powerhouses: Semaglutide vs.

D.SaimaitiA.et al (2022a)

A dedicated advocate for American health, his work spans diabetes, endocrine disorders, and broader quality improvement.

It promotes healthy hair by reducing oxidative stress and protecting hair follicles from damage

Association between somatostatin analogues and diabetes mellitus in gastroenteropancreatic neuroendocrine tumor patients: A Surveillance, Epidemiology, and End ResultsMedicare analysis of 5235 patients

"I wanted something that felt transparent, supportive, and realistic for my lifestyle." Nikki Glaser The Golden Globes host fiercly defended the use of Ozempic in March 2025, calling for people to be more open about using the medication